Guardian Pharmacy Services, Inc.
NYSE:GRDNMedical - Distribution
+$0.17 today
- Market cap
- $3.09B
- Beta
- 0.08
- P/E (TTM)
- 52.0
- EPS (TTM)
- $0.84
Volume 0.45M
Average 0.48M
GRDN Inventory
Cash effect of the change in inventory; building inventory consumes cash.
Guardian Pharmacy Services, Inc.NYSE: GRDN
Inventory · Q2 FY2026 · quarter ended Jun 2026
Inventory turns negative
Q2 FY2026 inventory was -$3.28M, compared with $405K a year earlier. Trailing-twelve-month inventory was -$5.48M. Over 3 fiscal years it compounded at -52.4% a year.
Context
- Inventory amounted to 0.1% of revenue in FY2025, unchanged from a year earlier.
- Inventory increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly inventory holds near -$3.28M or moves back toward the trailing-twelve-month quarterly average of -$1.37M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Inventory history
USD · from the cash flow
- Latest · FY2025
- (877K) USD
- Year-over-year change
- +23.8%
| Period | Period end | Inventory | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (877K) | +23.8% |
| FY2024 | 2024-12-31 | (1.15M) | -126.0% |
| FY2023 | 2023-12-31 | 4.43M | +154.5% |
| FY2022 | 2022-12-31 | (8.12M) | -3284.6% |
| FY2021 | 2021-12-31 | (240K) | — |
Inventory vs competitors
How GRDN compares with its peers on the latest reported figures
- GRDN's LTM Jun 2026 inventory of $5.48M is the 5th largest of the 11 companies compared; the peer median is $238K.
- Its year-over-year change of +101.8% is the 4th highest of 8, against a peer median of +12.2%.
- Inventory amounts to 0.4% of revenue for GRDN, versus a peer median of 2.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $167.8M | +12.2% | +8.3% | 6.3% | |
| LTM Jun 2026 | $18.57M | -9.1% | — | 3.0% | |
| LTM Sep 2026 | $18.1M | +328.0% | — | 3.9% | |
| LTM Mar 2026 | $15.24M | -30.8% | -1.7% | 4.7% | |
GRDNGuardian Pharmacy Services, Inc. | LTM Jun 2026 | $5.48M | +101.8% | -52.4% | 0.4% |
| LTM Jun 2026 | $3.3M | -899.4% | — | 2.7% | |
| LTM Jun 2026 | $552K | +200.0% | — | 0.3% | |
| LTM Sep 2026 | $476K | +23700.0% | -5.9% | 0.0% | |
| LTM Sep 2026 | $0 | — | — | — | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding GRDN) | $238K | +12.2% | -1.7% | 2.7% | |
Competitors are the stored peer set for GRDN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 28.33M | 49.66M | 37.72M | (71.03M) | 49.22M |
| Depreciation & Amortization | 16.53M | 16.56M | 18.23M | 19.77M | 22.34M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 3.07M |
| Stock-Based Compensation | 13.03M | (3.38M) | (6.09M) | 131.49M | 13.85M |
| Change in Working Capital | (1.47M) | (18.72M) | 15.6M | (29.41M) | 6.38M |
| Accounts Receivables | (7.71M) | (16.79M) | (14.3M) | (25.49M) | (8.55M) |
| Inventory | (240K) | (8.12M) | 4.43M | (1.15M) | (877K) |
| Accounts Payables | 9.78M | 13.37M | 6.3M | 13.23M | 16.4M |
| Other Working Capital | (3.3M) | (7.17M) | 19.18M | (16M) | (586K) |
| Other Non-Cash Items | 2.08M | 4.4M | 5.35M | 7.14M | 5.43M |
| Operating Cash Flow | 58.5M | 48.52M | 70.82M | 57.96M | 100.29M |
| Capital Expenditures | (9.28M) | (16.77M) | (14.56M) | (16.37M) | (19.58M) |
| Acquisitions (Net) | (4.4M) | (2M) | (985K) | (14.71M) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 535K | 874K | 2.1M | 671K | (12.68M) |
| Investing Cash Flow | (13.15M) | (17.9M) | (13.44M) | (30.41M) | (32.26M) |
| Debt Repayment | (6.1M) | (2.8M) | (2.89M) | (36.48M) | (4.98M) |
| Common Stock Issued | 0 | 0 | 0 | 119.78M | 27.45M |
| Common Stock Repurchased | 0 | 0 | 0 | (55.18M) | (29.04M) |
| Dividends Paid | (17.36M) | (30.8M) | (38.42M) | (35.75M) | 0 |
| Other Financing Activities | (13.34M) | (11.42M) | (15.92M) | (16.02M) | (497K) |
| Financing Cash Flow | (36.79M) | (45.03M) | (57.23M) | (23.65M) | (7.07M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 8.56M | (14.41M) | 145K | 3.91M | 60.96M |
| Free Cash Flow | 49.22M | 31.75M | 56.26M | 41.59M | 80.71M |
Guardian Pharmacy Services, Inc.
NYSE:GRDN
Intrinsic Alpha fair value
Locked
Current Price
$48.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.